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A B S T R A C T
A dermatophyte-specific PCR–reverse line blot (PCR-RLB) assay based on internal transcribed
sequences was developed. This assay allows the rapid detection and identification of nine clinically
relevant species within the three dermatophyte genera Trichophyton, Microsporum and Epidermophyton in
nail, skin and hair samples within 1 day. Analysis of 819 clinical samples (596 nail, 203 skin and 20 hair)
revealed a positive PCR-RLB result in 93.6% of 172 culture-positive and microscopy-positive samples.
PCR-RLB was superior to culture and direct microscopy, in both detection and species identification.
Comparison of identification results of 208 PCR-positive and culture-positive clinical samples showed
five discrepancies (2.4%) between PCR-RLB identification and classical microscopic ⁄ biochemical
identification of isolates. Comparison of PCR-RLB identification and classical identification of 98 other
isolates (dermatophytes and non-dermatophytes) revealed 13 discrepancies (13.3%) and five incomplete
identifications of Trichophyton spp. Sequence analysis of ITS1 regions of 23 samples with discrepant or
incomplete identification results (four Centraalbureau voor Schimmelcultures dermatophyte strains,
four clinical samples and 15 clinical isolates) confirmed identification results of PCR-RLB in 21 of the 23
analyzed samples. PCR-RLB proved to be extremely suitable for routine detection and identification of
dermatophytes directly in nail, skin and hair samples because it is rapid, sensitive, specific and accurate.
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I N T R O D U C T I O N
Dermatophytes are keratinophilic fungi that cause
superficial infections such as ringworm infection,
favus and onychomycosis. The dermatophytes
comprise three genera, Trichophyton, Microsporum
and Epidermophyton. Current laboratory diagnosis
relies on direct microscopic examination of KOH-
treated or lactophenol-treated clinical samples for
the presence of hyphae, microscopic and macro-
scopic observation of in vitro cultures, and metab-
olism tests. With direct microscopic examination
of samples, fungi can be detected, but it is
impossible to identify the species present in the
samples. Culturing has a low sensitivity (c. 75%)
and is time-consuming (2–4 weeks) [1]. Further-
more, identification of cultured isolates is diffi-
cult: 50 laboratories in The Netherlands scored
only 56% in identifying 1171 dermatophyte
isolates to the species level in proficiency
testing performed between 1991 and 2002
(R. G. F. Wintermans, unpublished data).
The aim was to develop a fast and sensitive
molecular method for detection and identification
of dermatophytes directly in clinical material.
Recent work has shown that internal transcribed
sequences (ITSs) between rRNA genes are
sufficiently polymorphic for identification of
dermatophytes to the species level [2–11].
A dermatophyte-specific PCR–reverse line blot
(PCR-RLB) assay [12] based on ITS1 sequences
using genus-specific and species-specific probes
for nine species within three genera and a DNA
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extraction procedure suitable for nail, skin and
hair samples was developed. Thus, 43 clinical
samples can be analyzed simultaneously for the
presence and identification of dermatophytes
within 24 h.
M A T E R I A L S A N D M E T H O D S
Strains and clinical samples
For development and specificity testing of the PCR-RLB assay,
22 reference dermatophyte strains (representing 18 species)
[13] from the Centraalbureau voor Schimmelcultures (CBS) in
Utrecht, The Netherlands, and 18 non-dermatophyte fungal
and bacterial isolates were used (Table 1). In addition, 98
clinical dermatophyte isolates, collected routinely from July
2002 until March 2004, many of which could not be identified
by classical laboratory diagnosis, were analyzed by PCR-RLB
for identification. This collection did not contain all strains
isolated in that period, but approximately all non-Trichophyton
rubrum and non-T. interdigitale strains, supplemented with 29
T. rubrum strains and 19 strains conventionally determined
to be anthropophilic T. interdigitale. As classical methods
are technically unable to distinguish T. interdigitale from
T. erinacei (the Trichophyton state of Arthroderma benhamiae),
any conventional identifications of T. interdigitale in this study
are presumptive identifications.
In order to determine the DNA extraction efficiency of the
lysis and extraction method, and the performance of the PCR-
RLB assay in clinical material, 819 clinical samples (596 nail
samples, 203 skin scales and 20 hair samples) from patients
suspected of suffering from dermatophytosis were collected
from July 2002 until March 2004. Each sample was randomly
divided into three portions of equal size: one for direct
microscopy, one for dermatophyte culture and subsequent
classical species identification, and one for PCR-RLB.
Classical detection and identification methods
For direct microscopy, nail and skin scale samples were cut
into small pieces and incubated in 30% KOH for 2 h (nail) or
30 min (skin) at room temperature. Hair samples were
immersed in 20% lactophenol. Subsequently, samples were
microscopically examined for the presence of hyphae or
conidia.
For dermatophyte culture, three pieces of nail, skin or hair
sample were put into Sabouraud agar plates containing
vitamin B1 and meropenem, with and without cycloheximide
[13]. Plates were sealed and incubated for up to 3 weeks at
30C. Isolates were identified to the species level by biochem-
ical tests and by macroscopic and microscopic examination,
with the omission of the bromocresol purple-milk solids–
glucose test [13].
Construction of internal control plasmid DNA
In order to prevent the occurrence of false-negative PCR
results, an internal control plasmid was added to each clinical
sample before DNA extraction to check for the efficient
recovery of DNA during DNA extraction, and to check for
the absence of PCR inhibitors in the DNA extracts. A plasmid
was constructed that carried the sequences complementary to
the dermatophyte primer sequences, and this was used as an
internal control during DNA preparation from clinical sam-
ples. For construction of the dermatophyte internal control,
forward and reverse primers were designed that carried the
dermatophyte 18S or 5.8S rRNA priming sites (DERMF1 and
B-DERMR2 respectively) and primer sequences encompassing
a 256-bp region of the bacterioferrin (tpf1) gene of Treponema
Table 1. Strains used for PCR–reverse line blot (PCR-RLB)
analytical specificity testing, with PCR-RLB and internal
transcribed sequence (ITS)1 sequence analysis results
Strain Reference PCR-RLB ITS1 sequence
Trichophyton
rubrum CBS 289.86 T. rubrum T. rubrum
interdigitale CBS 343.79 T. interdigitale T. interdigitale
interdigitale CBS 558.66 T. interdigitale ND
mentagrophytes CBS 572.75 T. mentagrophytes T. mentagrophytes
violaceum CBS 411.88 T. rubrum T. rubrum
violaceum CBS 319.31 T. violaceum ND
tonsurans CBS 219.32 T. tonsurans T. tonsurans
verrucosum CBS 134.66 T. verrucosum ND
erinacei sensu
stricto
CBS 511.73 Trichophyton sp. T. erinacei
schoenleinii CBS 335.32 T. mentagrophytes ND
concentricum CBS 109405 Trichophyton sp. 99.7% identical to
T. erinacei, 99.5%
identical to
T. concentricum and
T. erinacei
simii CBS 150.66 T. mentagrophytes 99.3% identical to
T. interdigitale, 98.9%
identical to T. simii,
probe region 100%
identical to
T. mentagrophytes
gloriae CBS 663.77 Fungus T. gloriae
terrestre CBS 464.62 Fungus ND
Microsporum
canis CBS 132.88 M. canis complex ND
audouinii CBS 109478 M. canis complex M. canis complex
audouinii CBS 404.61 M. audouinii ND
ferrugineum CBS 457.80 M. canis complex M. canis complex
duboisii CBS 349.49 Trichophyton sp. 99.1% identical to
M. duboisii
Epidermophyton
floccosum CBS 358.93 E. floccosum ND
floccosum CBS 566.94 E. floccosum E. floccosum
floccosum CBS 970.94 E. floccosum ND
Acremonium
sp. Clinical isolate ) ND
sp. Clinical isolate ) ND
Aspergillus
flavus Clinical isolate ) ND
fumigatus Clinical isolate ) ND
Candida albicans CBS 1893 ) ND
Chaetomium
sp. Clinical isolate ) ND
sp. Clinical isolate ) ND
Cladosporium
herbarum
Clinical isolate ) ND
Malassezia furfur Clinical isolate ) ND
Saccharomyces
cerevisiae ) ) ND
cerevisiae ) ) ND
Scopulariopsis
brevicaulis SKMM-98-IV-1A ) ND
brevicaulis Clinical isolate ) ND
brevicaulis Clinical isolate ) ND
Scytalidium
japonicum
Clinical isolate ) ND
Trichosporon
mucoides
CBS 7616 ) ND
Corynebacterium
jeikeium
RIVM strain ) ND
Staphylococcus
epidermidis
ATCC 12228 ) ND
ND, not done; ), negative.
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pallidum [14]. PCRs were run with Treponema pallidum, and the
PCR products were cloned directly into a TOPO TA vector
(Invitrogen, Groningen, The Netherlands). The plasmid was
isolated and purified with the Qiagen PlasmidMinikit (Hilden,
Germany) and used as an internal control in the DNA
extraction procedure and the dermatophyte PCR. The appro-
priate internal control plasmid concentration was determined
at 5000 copies by titration of the amount of internal control
DNA with serial dilutions of T. rubrum or T. verrucosum DNA
in a PCR-negative nail lysate pool followed by DNA isolation
and PCR-RLB. The compositions of the internal control
construction primers and probe are presented in Table 2.
DNA isolation and PCR amplification
Material for PCR-RLB was cut into small pieces and incubated
overnight at 55C in a lysis buffer (10 mM Tris-HCl, pH 8.0,
10 mM Na2EDTA, 100 mM NaCl, 80 mM dithiothreitol, 2%
sodium dodecylsulphate (SDS), and 1 mg ⁄ mL proteinase K).
Five thousand copies of internal control plasmid were added
to each sample, and subsequently, total DNA was isolated
using the QiaAmp DNA mini kit (Qiagen, Hilden, Germany).
The DNA was eluted in 50 lL of AE buffer, supplied with
the QiaAmp kit. Forward and reverse dermatophyte-specific
PCR primers were developed on the basis of dermatophyte
18S and 5.8S rRNA gene sequences, respectively, present in
the GenBank database. Reverse primer B-DERMR2 was
5¢-biotinylated in order to detect the PCR products by RLB
hybridization (Table 2). Five microlitres of the DNA from
clinical samples were used in 50-lL PCR reactions containing
15 mM Tris-HCl, pH 8.0, 50 mM KCl, 3 mM MgCl2, 200 lM
dATP, dCTP, and dGTP, 100 lM dTTP and dUTP, 600 nM
each primer (DERMF1 and B-DERMR2), 100 lg ⁄ mL of
bovine serum albumin, and 1.5 U of AmpliTaq Gold DNA
polymerase (Applied Biosystems, Nieuwerkerk a ⁄ d IJssel,
The Netherlands). Both positive and negative extraction and
PCR controls were included in each run. The following PCR
program was performed: 6 min at 95C, 40 cycles of 30 s at
95C, 30 s at 60C, and 1 min at 72C, followed by 2 min at
20C and chill at 4C. PCR products were analyzed by agarose
gel electrophoresis on 2% gels containing ethidium bromide,
and visualized by digital imaging.
Samples that showed PCR inhibition (no RLB signal
with either dermatophyte or internal control probes) were
re-extracted and re-analyzed by PCR using both undiluted and
1 : 5 diluted DNA extracts. In order to check for the presence
of amplifiable fungal DNA in dermatophyte PCR-negative
strains, a control PCR with generic fungal primers SR6R and
LR1 was performed on these strains as described previously
[6].
RLB
PCR products were analyzed by RLB to determine the
presence and origin of dermatophyte DNA. RLB was per-
formed as described previously [12], with some modifications.
Briefly, solutions with 5¢-amino-linked oligonucleotide probes
ranging from 400 to 3200 pmol ⁄ lane were coupled covalently
to an activated Biodyne C membrane in a line pattern with a
miniblotter (Immunetics, Cambridge, MA, USA). All probes
(maximum of 45 probes) were applied in triplicate to facilitate
reading of the films. After the oligonucleotide probes were
bound, the membrane was taken from the miniblotter,
incubated in 0.1 M NaOH for 10 min at room temperature,
washed in 2· SSPE (360 mM NaCl, 20 mM Na2HPO4.H2O,
2 mM EDTA) with 0.1% SDS at 42C and placed in the
miniblotter again with the oligonucleotide lines perpendicular
to the slots. Ten microlitres of the biotin-labeled PCR products
were diluted in 150 lL of 2· SSPE–0.1% SDS, and denatured
for 10 min at 100C. The denatured PCR products (maximum
of 45 products) were applied to the membrane immediately,
without incubation on ice. Following application of the
PCR products, the membrane was incubated in the miniblotter
for 10 min at 70C to maintain denaturation of the
Table 2. Sequences, positions and specificities of dermatophyte-specific PCR primers and reverse line blot (RLB) probes
used in this study
Name Sequence 5¢–3¢ Target Position
Amount of probe
in RLB (pmol ⁄ lane)
Primers
DERMF1 GGA AAC GAC CGC CCA GG 18S rRNA gene dermatophytes )103 from ITS1a NA
B-DERMR2 B-CGG AAT TCT GCA ATT CAC ATT ACT 5.8S rRNA gene dermatophytes 85a NA
Probes
Truso1 @-CAA GAA AAA ATT CTC TGA AGA G ITS1 T. rubrum ⁄ soudanense 204–225a 800
Tinte1 @-TAG TGG CTA AAC GCT GG ITS1 T. interdigitale 161a 400
Tment2 @-AGT GGC TCA ACG CTG G ITS1 T. mentagrophytes ⁄ schoenleinii 162a 3200
Tviol1 @-AGG AAA ATT CTC TGA AGG G ITS1 T. violaceum 206a 800
Ttons1 @-CTT TAT AGC GGC TCA ACG ITS1 T. tonsurans 158a 400
Tverr3 @-GAT CAG CGT TCC ATC AG ITS1 T. verrucosum 35a 1600
Mcafe1 @-GGG GAC TCT TGT TTC CT ITS1 M. canis complex 180b 3200
Maudo1 @-GGG GGA CTT TTG TTT CC ITS1 M. audouinii 179b 400
Efloc2 @-TAC GAA ATC TCC ATA GGT G ITS1 E. floccosum 129c 800
Trich4 @-AGC TGT CAG TCT GAG CG ITS1 Trichophyton genusd 224a 400
Micro1 @-CAC TCT TGA AAG AAC ATA CC ITS1 Microsporum genus 244b 800
Fung113 @-AAG TAA AAG TCG TAA CAA GGT 18S rRNA fungus (generic) )52 from ITS1a 800
TpF1 @-GCT ACA TAA CTA TCA CTG G TpF1 gene T. pallidum 156 400
Internal control construction primers
F1-TPF GGA AAC GAC CGC CCA GG A AAA AAA TAC CAC AGC ACC G 18S rRNA gene + T. pall. TpF1 )103 from ITS1a NA
R2-TPR2 CGG AAT TCT GCA ATT CAC ATT ACT- CTG TAA CAA CCG CTC GG 5.8S rRNA gene + T. pallidum TpF1 85a NA
B, 5¢-biotin label; @, aminolink label; ITS, internal transcribed sequence; NA, not applicable.
aITS1 sequence of T. rubrum.
bITS1 sequence of M. canis.
cITS1 sequence of E. floccosum.
dNot T. terrestre and T. gloriae.
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high-GC-content dermatophyte PCR products, and subse-
quently hybridized for 30 min at 45C. The membrane was
removed from the miniblotter and washed twice in 2· SSPE–
0.1% SDS for 6 min at 54C exactly. Subsequently, the
membrane was incubated for 30 min at 42C with streptavi-
din–peroxidase (Boehringer GmbH, Mannheim, Germany),
diluted 1 : 4000 in 2· SSPE–0.5% SDS, and washed twice for
6 min in 2· SSPE–0.5% SDS, and twice for 6 min in 2· SSPE.
Hybridization was visualized by incubating the membrane
with ECL detection liquid (GE Healthcare, Roosendaal, The
Netherlands) and exposing an ECL hyperfilm (GE Healthcare)
to the membrane for 10 min. The membrane with probes could
be re-used at least 20 times after stripping off the PCR products
by incubation of the membrane for 2 · 10 min at 82C in 1%
SDS.
Dermatophyte genus-specific and species-specific oligonu-
cleotide probes for RLB hybridization were developed on the
basis of dermatophyte ITS1 sequences present in the GenBank
database, and were 5¢-aminolink-labeled. Probe Tinte1 was
developed for the detection of anthropophilic T. interdigitale
strains. Probe sequences, targets and concentrations are shown
in Table 2.
Analytical sensitivity
In order to determine the lower limit of detection of the PCR-
RLB assay, serial ten-fold dilutions of T. verrucosum and of
Microsporum canis DNA were made in pooled DNA extracts
from culture-negative and PCR-negative nail samples. Five
microlitres of each dilution were used in 50-lL PCR reactions.
The lowest DNA concentration that yielded an RLB signal was
considered as the limit of detection of the PCR-RLB assay.
DNA sequence analysis of PCR products
Single-stranded DNA sequence analysis was performed on
PCR products using the BigDye Terminator Cycle Sequencing
kit v1.1 (Applied Biosystems) and PCR primer DERMF1
(Table 2). DNA sequencing products were analyzed on an
ABI Prism 310 Genetic Analyzer (Applied Biosystems).
All DNA sequence analyses were performed at the Laboratory
for Infectious Diseases in Groningen, The Netherlands. The
obtained DNA sequences were compared to all sequences of
the GenBank database using the DNA comparison program
BLASTN.
R E S U L T S
Specificity of the PCR-RLB assay
To determine the analytical performance of the
PCR-RLB method, DNA from 14 CBS reference
strains representing the ten most clinically rele-
vant dermatophyte species were analyzed first:
T. rubrum, T. interdigitale (two strains), T. mentag-
rophytes (as phylogenetically redefined by Gra¨ser
et al. to include only the former T. mentagrophytes
var. quinckeanum [4]), T. violaceum, T. tonsurans,
T. verrucosum, T. soudanense, M. canis, M. audoui-
nii (two strains) and Epidermophyton floccosum
(three strains). All analyzed CBS dermatophyte
reference strains hybridized with their species-
specific probes, except for one of the two strains
identified as M. audouinii at the CBS
(CBS 109478), which reacted with the M. canis
complex-specific probe (Table 1). All tested Trich-
ophyton species also hybridized with the Tricho-
phyton genus-specific probe, and all tested
Microsporum species also hybridized with the
Microsporum genus-specific probe. Subsequently,
CBS reference strains from other, less frequently
isolated, dermatophyte species were used in
order to analyze the performance of the PCR-
RLB assay; T. erinacei sensu stricto (CBS 511.73),
T. concentricum (CBS 109405), T. schoenleinii
(CBS 335.32), and T. simii (CBS 150.66), for which
no species-specific probes were present on the
membrane, all reacted with the Trichophyton
genus-specific probe, as expected. Both T. schoen-
leinii (CBS 335.32) and the strain formerly identi-
fied as T. simii at the CBS (CBS 150.66) reacted
with the T. mentagrophytes-specific probe. T. glo-
riae and T. terrestre (two clinically irrelevant,
geophilic species) reacted only with the general
fungus probe. M. ferrugineum (CBS 457.80),
belonging to the M. canis complex, reacted with
the Microsporum genus-specific probe and with
the M. canis complex probe, as expected (identical
ITS1) (Table 1).
Strains with discrepant or unexpected PCR-RLB
results were subjected to ITS1 sequence analysis
(see Results section, ITS1 sequence analysis).
Detection efficiency of the PCR-RLB assay in
clinical samples
The PCR-RLB method allowed the detection of
100 fg to 1 pg of dermatophyte DNA, correspond-
ing to 2–20 dermatophyte cells (assuming that the
size of a dermatophyte genome is 40 Mbp) [15].
This detection limit was determined with the
Trichophyton and Microsporum genus-specific
probes and the T. verrucosum and M. canis spe-
cies-specific probes in the presence of 500 copies
of internal control DNA.
All analyzed non-dermatophyte isolates
remained negative in the dermatophyte-specific
PCR-RLB (Table 1), and were positive in a control
PCR with generic fungus primers SR6R and LR1
described earlier, which proves that the
non-dermatophyte DNA extracts contained
amplifiable fungal DNA (data not shown) [6].
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All 819 clinical samples were analyzed by PCR-
RLB, microscopy and culture. Fig. 1 shows a
typical result of PCR-RLB of some clinical sam-
ples and of a number of dermatophyte isolates.
One of the 819 samples (microscopy-negative
and culture-negative) repeatedly inhibited the
PCR, even with a 1 : 5 dilution of the DNA. This
sample was excluded from further analyses.
Table 3 presents the results for the remaining 818
samples; 353 (43.2%) were positive using PCR-
RLB, 293 (35.8%) were positive using direct
microscopy, and 230 (28.1%) were positive in
dermatophyte culture. PCR-RLB results were
compared to those of microscopy, dermatophyte
culture, and the classical standard (CS) that were
defined for this study, using the stringent criteria
that samples are assumed to be positive if both
dermatophyte culture and direct microscopy
are positive, and negative if both dermatophyte
culture and direct microscopy are negative. If
culture and microscopy are not concordant, i.e.
one is positive and the other is negative, samples
are called indeterminate. The performance of PCR-
RLB compared to the CS was 93.6% (161 ⁄ 172).
Considering all 818 analyzed samples, PCR-
RLB yielded more positive results than direct
microscopy alone or culture alone. Seven of 11
PCR-negative, CS-positive samples had sufficient
material for re-extraction and re-analysis by PCR-
RLB, and only one was found to be positive
during re-analysis. Seventeen of 33 PCR-negative,
culture-negative and microscopy-positive sam-
ples (51.5%) showed growth of other, non-der-
matophyte fungi such as Acremonium, Alternaria,
Aspergillus, Candida, Penicillium, Pseudallescheria,
Rhodotorula, and Trichosporon species. Eight of 11
PCR-negative, culture-positive and microscopy-
negative samples contained T. rubrum, and three
contained T. interdigitale, as determined by
classical identification. Three nail samples and a
skin sample could be re-extracted and re-analy-
zed by PCR-RLB; all four samples remained
negative.
Performance of assays in different sample types
Percentages of positivity of the three assays were
determined in three different sample types. Con-
sidering all 596 nail samples, culture performed
significantly less well (28%) than PCR-RLB (47%)
and microscopy (42%) with regard to fungus
detection (chi-square test, p £0.001 and p £0.001,
respectively). The efficiency of classical species
identification of isolates from cultured nail sam-
ples was also lower than that of PCR-RLB in nails
(27% vs. 46%, respectively). With direct micro-
scopic examination, identification of fungi is not
possible in most cases. Microscopy performed
Fig. 1. Typical result of reverse line blot hybridization of
dermatophyte PCR products from clinical samples and
from isolates. Horizontal lanes: genus-specific and species-
specific oligonucleotide probes (three lanes per probe).
Vertical lanes: PCR products from clinical samples
(lanes 1–30) and from dermatophyte isolates (lanes 32–39).
Table 3. Detection of dermato-
phytes by PCR–reverse line blot
(PCR-RLB), as compared to direct
microscopic examination, dermato-
phyte culture and classical standard
in 818 clinical samples (nail, skin
and hair)
PCR-RLB
Microscopy
(n = 818)
Culture
(n = 818)
Classical standard method
(n = 818)
Positive Negative Positive Negative Positive Negative
Indeterminate
m+ ⁄ c)
Indeterminate
m) ⁄ c+
Positive 249 104 208 145 161 57 88 47
Negative 44 421 22 443 11 410 33 11
Total 293 525 230 588 172 467 121 58
Indeterminate m+ ⁄ c), classical standard indeterminate (microscopy-positive and culture-negative); Indeterminate
m) ⁄ c+, classical standard indeterminate (microscopy-negative and culture-positive).
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significantly less well in detecting fungi in all 202
skin samples (21%) and in all 20 hair samples
(10%) as compared to PCR-RLB (32% and 45% in
skin and in hair samples, respectively; p £0.025
and p £0.025, respectively). Microscopy also
scored significantly lower in hair samples (10%)
as compared to culture (40%; p £0.05). No signif-
icant difference in performance was observed
between culture and microscopy in skin samples
(29% and 21%, respectively), or between culture
and PCR-RLB in skin samples (29% and 32%,
respectively). In all three sample types, PCR-RLB
yielded the highest percentage of positives and of
species identifications.
Identification efficiency of the PCR-RLB assay
Two hundred and eight clinical samples were
positive according to both PCR-RLB and culture.
PCR-RLB identification results of the dermato-
phytes present in these 208 samples were com-
pared with those obtained by combined
biochemical, macroscopic and microscopic analy-
sis of the culture-positive samples. Among those
208 samples, five identification discrepancies
(2.4%) were found between PCR-RLB and cul-
ture. In addition, eight samples could not be
completely identified by PCR-RLB, and another
sample was incompletely identified by classical
methods (Table 4, ‘Trichophyton sp.’).
PCR-RLB was also used to identify 98 other
(dermatophyte and non-dermatophyte) isolates
(data not shown), many of which yielded diffi-
culties with determination to the species level
using classical methods. Among these 98 isolates,
13 identification discrepancies (13.3%) were
found. Four of these discrepant cases were
classically identified as T. tonsurans, whereas
PCR-RLB identified all four isolates as T. interdig-
itale. In addition, two samples were incompletely
identified as Trichophyton sp. by PCR-RLB, and as
T. interdigitale by classical methods. Three other
samples were incompletely identified as Tricho-
phyton sp. by classical methods. All three isolates
were identified as T. rubrum by PCR-RLB. One
isolate identified as T. violaceum by classical
methods proved to be a non-dermatophyte by
PCR-RLB.
ITS1 sequence analysis
DNA sequence analysis of ITS1 regions was
performed on 13 dermatophyte CBS reference
strains (four of which gave discrepant PCR-RLB
results as compared to the classical determina-
tion, Table 1), and on 19 discrepant test samples
(four clinical samples and 15 clinical isolates), and
it confirmed PCR-RLB-based identification results
in 21 of 23 discrepant cases. The first sample that
had a discrepancy between PCR-RLB and ITS1
sequencing results was CBS strain 349.49, deter-
mined to be Trichophyton sp. by PCR-RLB, and to
be M. duboisii by classical methods at the CBS.
The ITS1 sequence obtained from this isolate was
identical to the only M. duboisii ITS1 sequence in
the GenBank database, which is derived from
this CBS strain 349.49. Classical identification
methods revealed no unambiguous identity. The
other discrepant sample was CBS strain 150.66,
determined to be T. simii at the CBS, and to be
T. mentagrophytes by PCR-RLB. ITS1 sequence
analysis revealed the highest sequence identity
(99.3%) with T. interdigitale (A. vanbreuseghemii,
accession no. AB246678), and up to 98.2%
sequence identity (accession no. AF170454) with
the T. simii ITS1 sequences in the database. In all
other cases with discrepant results between PCR-
RLB and classical methods, PCR-RLB results were
Table 4. Identification results of 208 PCR–reverse line blot (PCR-RLB)-positive and dermatophyte culture-positive clinical
samples
Culture
PCR-RLB
TotalTrichophyton rubrum T. interdigitale T. mentagrophytes T. violaceum T. tonsurans Trichophyton sp. Microsporum canis M. audouinii
T. rubrum 144 2 146
T. interdigitale 1 31 5 37
T. mentagrophytes 2 1 2 5
T. violaceum 3 1 4
T. tonsurans 3 3
Trichophyton sp. 1 1
M. canis 7 7
M. audouinii 5 5
Total 147 34 1 3 3 8 7 5 208
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confirmed by ITS1 sequence analysis. For exam-
ple, both PCR-RLB and ITS1 sequence analysis
revealed M. audouinii (CBS 109478) to be M. canis,
and T. soudanense (CBS 411.88) to be T. rubrum
(Table 1). The ITS1 sequences from three clinical
samples that reacted with the Trichophyton genus-
specific probe only were determined, and proved
to be T. erinacei (the Trichophyton state of A. benh-
amiae). One of these sequences originated from an
isolate presumptively identified as T. interdigitale
by classical methods, and the remaining two were
from clinical samples with negative cultures.
D I S C U S S I O N
The current diagnostic tools for dermatophyte
infections are directmicroscopy anddermatophyte
culture, followed bymacroscopic, microscopic and
biochemical analysis. Both assays have disadvan-
tages: with direct microscopic examination of
samples, it is impossible to identify the fungal
species present in the samples, and culturing has a
low sensitivity and is time-consuming. Further-
more, classical identification of cultured isolates is
difficult. Previous reports describe PCR assays for
the detection of dermatophytes in clinical material
that are only moderately sensitive [16–20] or are
unable to identify dermatophytes to the species
level [19,21–26]. Other PCR-based assays can iden-
tify only one or a few dermatophyte species
[16,18,20,27–30], or are not used directly on clinical
material [31,32]. Most assays were tested only on
nail samples, and not on skin or hair samples. Some
assays used nested (double-round) PCRs, which
are known to have a high risk of contamination
[20,25,26]. Normally, if efficient DNA extraction
and PCR protocols are in place, single-round PCR
will be sufficiently sensitive. One recent report
describes the detection and identification of der-
matophytes in clinical material by 18S rRNA PCR
and subsequent sequence analysis, which is a
rather expensive method that is not affordable in
every routine laboratory [33].
A PCR-RLB assay was developed in conjunc-
tion with an efficient DNA extraction method, for
direct detection and identification of dermato-
phytes in clinical material such as nail, skin scale
and hair samples. This PCR-RLB assay proved to
be extremely suitable for routine laboratory diag-
nosis of dermatophytosis because of its fast,
sensitive, specific and accurate performance,
and the requirement for relatively simple and
inexpensive equipment; the assay is two to three
times less expensive than PCR with subsequent
sequence analysis (according to Dutch tariff
guidelines). Within one RLB run, up to 45 differ-
ent PCR products (clinical samples) can be anal-
yzed, with up to 45 probes representing different
dermatophyte genera and ⁄ or species.
PCR-RLB results are available on the day
following collection, whereas culture takes
3–6 weeks to produce definite results. This repre-
sents a major improvement in the speed of
dermatophyte diagnostics. Physicians often start
antimycotic therapy at the time that a sample is
taken for dermatophyte culture and microscopy.
This implies that up to 50% of the patients
suspected of having dermatophytosis receive
unnecessary antimycotic therapy for 3–6 weeks,
as in this study it was shown that c. 50% of the
samples did not contain dermatophytes. The
rapid PCR-RLB method provides the opportunity
for physicians to start antimycotic therapy after
PCR-RLB results are known, so that only patients
with proven dermatophyte infection receive
antimycotic therapy. Estimated mean costs for
classical diagnostics of dermatophytosis, i.e. com-
bination of culture with direct microscopy, are
US $31 per patient, as compared to US $90 per
patient for PCR-RLB (according to Dutch tariff
guidelines). This implies that the costs of PCR-
RLB diagnostics are c. US $59 per patient higher
than those of classical diagnostics. However, as
PCR-RLB results are obtained within c. 3–4 days
after sampling (if the assay is performed twice
weekly, as in our laboratory), physicians will
await PCR-RLB results and initiate antimycotic
therapy only for patients with PCR-proven der-
matophytosis. This procedure results in antimy-
cotic therapy in c. 50% fewer patients (those with
PCR-negative results, who would have been
treated for 1 month if culture was used as the
diagnostic test), which means an average cost
reduction of c. US $35 per patient. A very impor-
tant advantage of using PCR-RLB for diagnosis of
dermatophytosis is the fact that c. 50% of patients
suspected of suffering from dermatophytosis
will not receive unnecessary therapy with
antimycotics, and thus will not experience the
often uncomfortable side effects of these agents.
A disadvantage of PCR is the risk of false-positive
results, caused by either pre-PCR contamination
of samples or by amplification of DNA from dead
cells.
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The PCR-RLB method was shown to have a
clinical performance of 93.6% using the CS
method (Table 3), and a detection limit of 2–20
dermatophyte cells, which is superior to the
detection limit of 200–700 cells (10–35 pg) found
in two previously described PCR-based assays,
and comparable to the detection limit of the real-
time assay described by Arabatzis et al. [25,28,34].
Fifty-seven of 818 samples were positive accord-
ing to PCR-RLB and negative according to both
other assays. The phenomenon that PCR-based
diagnostic assays detect substantially more posi-
tives than the CS method is an often-encountered
problem. It cannot be excluded that some of these
samples are false-positives, caused by non-spe-
cific amplification, or by amplification of DNA
from dead dermatophytes, or by pre-PCR con-
tamination of samples. We have shown that the
PCR-RLB method is highly specific, and all PCRs
were performed in three strictly separated rooms
using both extraction and PCR run controls.
Therefore, the chance of false-positivity due to
non-specific amplification or contamination is
negligible. In order to prove that those 57 PCR-
positive samples indeed did contain live derma-
tophytes, the clinical outcome of the antimycotic
therapy of those patients should be analyzed.
More than half of the PCR-RLB-negative, derma-
tophyte culture-negative and microscopy-positive
samples (51.5%) showed growth of other, non-
dermatophyte fungi, some of which may have
been involved in onychomycosis or dermatolog-
ical infections. Another likely explanation for part
of this category of cases with positive microscopy
is the occurrence of old dermatophyte infections
sampled in areas where the fungal hyphae
were already dead and no dermatophyte DNA
remained. The rigid chitin ⁄ glucan fungal wall
persists in nails and in skin lesions long after
other elements are gone, and these samples will
yield positive microscopy results, while culture
and PCR results will be negative.
PCR-RLB was superior to culture and direct
microscopy, both in detection and in species
identification. Analysis of results obtained with
different sample types showed that the PCR-RLB
performed better than culture and direct micros-
copy, whatever the sample type. Some of the
discrepancies in positivity found among the three
assays may be due to sampling errors, as the
clinical material used cannot be homogenized
before the samples are divided. The samples were
divided randomly, so that the chance of dealing
with selection bias is as small as possible. Culture
seemed to have a very low level of detection when
using nails, compared to direct microscopy and
PCR-RLB, which also resulted in a lower percent-
age of samples in which a dermatophyte species
could be identified. Although only 20 hair sam-
ples were analyzed in the current validation
study, the results show very clearly that direct
microscopic analysis is not the method of choice
when using hair samples, as only 10% were
found to be positive by microscopy, whereas
culture and PCR-RLB performed almost equally,
with 40% and 45% positivity, respectively. Using
skin scales, direct microscopy also has the lowest
performance (21% positivity) of the three meth-
ods used. As already mentioned, a major draw-
back of direct microscopic examination of
samples is the absence of identification possibil-
ities in fungi. Advantages of direct microscopic
assays are the easy performance and low cost;
culture-based diagnostic methods have the advan-
tages of a relatively low cost, and the possibility of
storing live clinical isolates for future (phenotypic
or genotypic) analysis.
Two recently described PCR-based assays have
identification possibilities that are comparable
to this PCR-RLB assay. The first, developed by
Li et al., is a well-evaluated dermatophyte iden-
tification assay, with good sensitivity and speci-
ficity when tested with isolates [32]. The assay has
not been evaluated with clinical samples yet. The
oligonucleotide arrays were produced using an
Ezspot arrayer, an instrument that is not afford-
able for most diagnostic laboratories. Another
drawback of the assay developed by Li et al. is the
fact that each PCR product requires analysis on a
separate array membrane that cannot be re-used.
The second recently described assay, developed
by Arabatzis et al., is a rapid and sensitive real-
time detection ⁄ identification PCR assay for com-
mon dermatophyte infections [34]. An important
disadvantage of their strategy is the high cost, due
to the fact that for each clinical sample, three
separate real-time PCR reactions are performed:
two reactions for the detection of all clinically
relevant dermatophyte species, and a third for the
detection of an internal control. Furthermore,
several species are not unambiguously identi-
fied by the real-time method; the members of
the T. mentagrophytes complex (T. interdigitale,
T. mentagrophytes and T. erinacei) cannot be
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distinguished from each other, T. verrucosum can-
not be distinguished from the T. mentagrophytes
complex species, and M. audouinii needs to be
distinguished from M. canis complex strains on
the basis of relative signals with two different
probes, due to cross-reactivity of probes. Addi-
tionally, the real-time assay of Arabatzis et al. was
not extensively validated; only 92 clinical samples
were analyzed, and T. tonsurans and M. canis
were not encountered among those samples.
This validation study showed that identifica-
tion of dermatophyte isolates by macroscopic and
microscopic examination and biochemical tests is
difficult, partly because not all available identifi-
cation tests are used in most routine diagnostic
laboratories. Comparison of classical identifica-
tion results with PCR-RLB identification results
revealed five discrepancies (2.4%) among 208
routine clinical samples and 13 discrepancies
(13.3%) among 98 clinical isolates. The high
percentage of discrepancies among isolates might
be explained by the fact that many of those
isolates were difficult to identify phenotypically.
In clinical samples, the vast majority of the
dermatophytes found are T. rubrum (70.7%) and
T. interdigitale (16.3%) as determined by PCR-
RLB. Thus, in routine clinical samples, the variety
among species is much less than in the set of
98 clinical isolates that were analyzed. Using
classical identification, a higher number of
T. mentagrophytes, and a much lower number of
Trichophyton spp. were found, than by PCR-RLB.
Sequence analysis of some PCR products identi-
fied as Trichophyton sp. by PCR-RLB revealed
A. benhamiae ITS1 sequences. It is possible that the
isolates identified as T. mentagrophytes or T. inter-
digitale by classical methods are members of the
taxa around T. mentagrophytes, T. interdigitale and
T. tonsurans, reclassified as T. erinacei (A. benhami-
ae) or T. simii, on the basis of the molecular data of
Gra¨ser et al. [4]. It might be difficult, or even
impossible, to distinguish those species from
T. mentagrophytes or T. interdigitale by classical
identification. Those species have ITS1 sequences
that differ slightly from those of T. mentagrophytes
and T. interdigitale, so in this PCR-RLB assay they
only give a signal with the Trichophyton genus
probe, and thereby were incompletely identified
as Trichophyton sp. Currently, we are testing an
A. benhamiae-specific probe, and have already
found several new clinical samples reacting with
that probe. With classical identification, a species
name is almost always given to an isolate, even if
its characteristics are not 100% concordant with
those of the species name assigned to it. In
contrast, with PCR-RLB identification, the isolate
is assigned a species name only if one of the probe
sequences on the membrane has a complete
match with the ITS1 sequence of that isolate;
otherwise, it is incompletely identified as Tricho-
phyton sp. Samples with identification results
discrepant between PCR-RLB and classical iden-
tification methods have been subjected to ITS1
sequence analysis. Comparison of the sequencing
data with the EMBL and GenBank sequence
databases showed the same species designation
as assigned by PCR-RLB in 21 of 23 samples. This
means that the probes used in the PCR-RLB
method are sufficiently specific for identifica-
tion of dermatophytes to the species level. The
only misidentified cases were the M. duboisii
CBS 349.49 strain and the T. simii CBS 150.66
strain. PCR-RLB identified the CBS 349.49 strain
as a Trichophyton species, and ITS1 sequencing
revealed 100% identity with its own sequence.
Microscopic and biochemical analysis revealed
that the characteristics of the isolate most resem-
bled those of a Trichophyton species; macroconidia
were smooth and polycellular (although thick-
walled, which is more characteristic of Micro-
sporum). M. duboisii has been shown not to be a
clinically relevant species, as its isolation has
been reported only once, in 1964 [35]. It would
be useful to re-analyze this isolate in one or
two reference laboratories to clarify its classifi-
cation. T. simii (CBS 150.66) reacted with the
T. mentagrophytes-specific probe, and ITS1 seq-
uence analysis showed the highest similarity
with a T. interdigitale (A. vanbreuseghemii) isolate
(99.3%). The probe region of this CBS strain was
100% identical to our T. mentagrophytes-specific
probe sequence. Strain CBS 150.66 is a mated
T. simii isolate (mating type minus), which was
probably confirmed as T. simii at the CBS prior to
the days of ITS sequence analysis. The genetic
variability within T. simii has not been extensively
explored. This strain is most probably a member
of the T. mentagrophytes complex described by
Gra¨ser et al., which comprises many closely
related variants with very little variation in their
ITS regions [4]. T. schoenleinii is identified as
T. mentagrophytes by PCR-RLB, as they have
identical ITS1 sequences. T. schoenleinii is very
closely related to T. mentagrophytes, but is still
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considered to be a separate species, on the basis of
molecular data from Gra¨ser et al. [4]; it can be
distinguished from T. mentagrophytes by ITS2
sequence analysis. T. soudanense (CBS 411.88)
reacted with the T. rubrum ⁄ T. soudanense probe,
as expected. The classification of this species is
still unclear; in the second edition of the Atlas of
Clinical Fungi [13] it is renamed as T. violaceum,
on the basis of ITS1 + 2 sequencing. Currently,
Gra¨ser et al. have proposed it as a synonym of
T. rubrum. ITS1 sequencing of strain CBS 411.88
revealed the highest similarity with T. rubrum, so
it should be analyzed further. The clinical isolate
that was classically identified as T. violaceum and
as a non-dermatophyte by PCR-RLB needs to be
subjected to ITS sequence analysis in order to
determine its identity. T. gloriae and T. terrestre
did not react with the Trichophyton genus-specific
probe. These two species are clinically irrelevant
geophilic species, and their ITS1 sequences are
highly divergent from those of the clinically
relevant Trichophyton species.
In conclusion, the PCR-RLB assay described in
this study was demonstrated to be an assay with
excellent performance characteristics, which con-
tributes to a major improvement in the diagnosis
and the concurrent therapy of dermatophytosis.
The PCR-RLB assay described in this study could
be considered as a replacement for both direct
microscopy and culture for laboratory diagnosis
of dermatophytosis.
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